Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESPB for Pain Control in Flank or Anterior Subcostal Incision Surgery
NCT03691935Phase 4Terminated
- Sponsor
- Penn State Health Milton S. Hershey Medical Center
- Start
- Sep 2018
- Primary completion
- Jan 2024
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain (2 arms), sponsored by Penn State Health Milton S. Hershey Medical Center. Primary endpoint: Visual Analogue Scale Pain Score at 3 days. Started Sep 2018; status: terminated.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03691935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03691935.